Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1518-1531
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1518
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1518
Figure 3 Kaplan-Meier curves of overall survival.
The overall survival of the groups was compared using the log-rank test and included the entire follow-up period. Significant difference is observed in survival time between the 1,2-Dimethylhidrazine dihydrochloride-capecitabine (DMH-C) group (in orange) and DMH-C-probiotics group (in blue) (P = 0.0001). This Figure is original for this work. DMH: 1,2-Dimethylhidrazine dihydrochloride; C: Capecitabine; P: Probiotics.
- Citation: Gigola G, Carriere P, Novoa Díaz MB, Perdigon G, Zwenger AO, Gentili C. Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine. World J Gastrointest Oncol 2021; 13(10): 1518-1531
- URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1518.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1518